Fosamax Plus D Oral Tablet, Weekly 70-2800iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Fosamax Plus D: Oral tablet, weekly (70-2800IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_10033.JPG
Fosamax Plus D Tab
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: LOGO  |  710

What is this Medicine?

ALENDRONATE; CHOLECALCIFEROL (a LEN droe nate; KOL e cal SIF er ol) has two medicines to help reduce calcium loss from bones and to increase the production of normal, healthy bone in patients with osteoporosis.

CVS Pharmacy Patient Statistics for Fosamax Plus D: Oral tablet, weekly(70-2800IU)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Fosamax Plus D 70mg-2800units Tablet

NDC: 000060710
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Osteoporosis

Storage Information
Protect from light
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Fosamax Plus D 70mg-2800units Tablet
Drug Image file DrugItem_10033.JPG
Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.
Pill Identification: LOGO  |  710
Shape: oblong
Color: white

Reported Side Effects for Fosamax Plus D 70mg-2800units Tablet

Stomach Ulcer Incidence:
<1.1%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<3.6%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
<3.1%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<4.1%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
0.1-0.5%*
Severity: MILD
Onset: EARLY
Throat Ulcers Incidence:
0.1-1.5%*
Severity: SEVERE
Onset: DELAYED
Difficulty Swallowing Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
0.2-1.1%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
0.2-1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
0.4-4.1%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
0.4-4.1%*
Severity: MILD
Onset: EARLY
Bone Pain Incidence:
0.4-4.1%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
0.4-4.1%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
0.6-3.1%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
0.7-2.8%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
0.9-6.6%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.1-3.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Fosamax Plus D 70mg-2800units Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Food and Fosamax Plus D 70mg-2800units Tablet(Alendronate Sodium)
Food and Alendronate Sodium(Alendronate Sodium)
Take Alendronate with water only, on an empty stomach at the start of the day. Taking Alendronate with food may decrease the actions of the drug. Take Alendronate at least 30 minutes before any other beverage, food, or other medication for the day. In particular, avoid dairy products and orange juice within 2 hours of this drug. Also avoid laying down for at least 30 minutes after taking this medicine. To avoid irritation to the esophagus (tube connecting mouth to the stomach), this medicine must be taken as directed.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fosamax Plus D

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.